Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Aneurysm Clinical Trials

A listing of Aneurysm medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (14) clinical trials

Angiotensin 2 Receptor (AT2R) in Endothelial Cells in Preeclampsia

Trial Design: The study is a comparison of two cohorts, those with and without preeclampsia during pregnancy. The study team plans to investigate role of AT2 in modulation of vascular function/dysfunction using vessels isolated from the omental biopsies by examining for the evidence of fetal vascular dysfunction mediated by decreased ...

Phase N/A

Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV

This pilot study will enrol 70 WLWH aged 25-64, with no history of cervical abnormalities attending 4 HIV clinics in the UK. Participants will be asked to complete an entry survey in which behavioural information, gynaecological and sexual history, will be collected, with the aim of characterising the study population ...

Phase N/A

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

The Registry conforms to the FDA Guidance for Industry: Establishing Pregnancy Exposure Registries, the Guidelines for Good Pharmacoepidemiology Practices, and the FDA Guidance on Pharmacovigilance. The Antiretroviral Pregnancy Registry collects data on use of the following GSK drugs: abacavir, amprenavir, delavirdine, fosamprenavir, lamivudine, maraviroc, zidovudine, and their combinations during pregnancy. ...

Phase N/A

Intra-abdominal Umbilical Vein Aneurysm

Intra-abdominal umbilical vein aneurysm is a rare pathology of the fetal venous system. Its incidence is low, evaluated between 0.4 and 1.1 / 1000. Intra-abdominal umbilical vein aneurysm is identified as an oval or rounded, anechoic mass located between the abdominal wall and the lower edge of the liver. It ...

Phase N/A

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

The following antiretroviral drugs are followed by the Antiretroviral Pregnancy Registry (APR, Registry) to detect any major teratogenic effect when administered to pregnant women: abacavir (ZIAGEN, ABC), abacavir/lamivudine combination (EPZICOM, KIVEXA, EPZ), abacavir/lamivudine/zidovudine combination (TRIZIVIR, TZV), abacavir/dolutegravir/lamivudine combination (TRIUMEQ, TRI), adefovir dipivoxil (HEPSERA, ADV), amprenavir (AGENERASE, APV), atazanavir (REYATAZ, ATV), ...

Phase N/A

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

More than 150,000 babies became infected with HIV in 2015 alone. When HIV drugs are started before or early in pregnancy, HIV positive women can give birth to HIV negative baby. This is possible because HIV drugs can reduce the amount of the virus in the body to the extent ...

Phase N/A

Fistula Formation and Successful Repair

This is a prospective and retrospective chart review of a cohort of women aged 12 years and above who present to Bwaila Hospital with obstetric fistulas. Variables from existing subject records tracing back to January 2010 will be input into the REDCap database and analyzed. Prospective data collection will begin ...

Phase N/A

Prospective Cohort Evaluating Pregnancy Rates PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA

Objective 1: To compare the typical-use pregnancy rates of 710 HIV+ DMPA-users on EFV with 710 HIV+ LNG implant users on EFV through a prospective observational cohort. The investigators will enroll 710 HIV-infected women on EFV who are initiating the LNG implant and 710 HIV-infected women on EFV who are ...

Phase N/A

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

The following agents will be studied: Etravirine, Intelence, TMC125; Emtricitabine, Emtriva or FTC; Tenofovir, Viread, TDF; Atazanavir, Reyataz; Fosamprenavir, Telzir, FPV; Darunavir, Prezista, TMC114; Tipranavir, Aptivus, TPV; Indinavir, Crixivan; abacavir; raltegravir, Isentress; Enfuvirtide, Fuzeon; Maraviroc, Celsentri; dolutegravir; elvitegravir/cobicistat; rilpivirine, TAF, darunavir/cobicistat

Phase N/A

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

Efavirenz-based antiretroviral therapy is effective in treating HIV and had become standard in the World Health Organization (WHO) guidelines. However, despite its effectiveness in lowering viral load, there is also solid evidence that it decreases the effectiveness of etonogestrel-releasing implants. This presents a difficult clinical scenario in countries where the ...

Phase N/A